|
| |
Articles
1-300 out of 600 article(s) next
| Title |
Author |
Type |
Date |
Words |
| Why swine flu virus develops drug resistance. |
|
|
May 30, 2012 |
370 |
| New protein may fight flu outbreak. |
|
|
May 28, 2012 |
296 |
| Gilead Files European Marketing Application for Boosting Agent Cobicistat. |
|
|
May 23, 2012 |
809 |
| Mylan Launches Generic Version of Viramune Tablets. |
|
|
May 23, 2012 |
468 |
| Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months. |
|
|
May 21, 2012 |
690 |
| FDA Approves New Labeling for ISENTRESS[R] (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1. |
|
|
May 21, 2012 |
2398 |
| Anti-HIV drug tenofovir 'safe to take during pregnancy'. |
|
Medical condition overview |
May 16, 2012 |
428 |
| 'Switch' that boosts 'innate immunity' to ward off infectious diseases discovered. |
|
|
May 12, 2012 |
481 |
| FDA Advisory Committee Supports Approval of Gilead's Truvada[R] for Reducing the Risk of Acquiring HIV. |
|
|
May 11, 2012 |
982 |
| FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single Tablet Regimen for HIV. |
|
|
May 11, 2012 |
941 |
| University of Washington, University of Texas Medical Branch and Kineta, Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development. |
|
|
May 8, 2012 |
1293 |
| Research and Markets: Hepatitis C Virus - Protease Inhibitors Bring Change in the Treatment Paradigm for Hepatitis C Virus Infection - What Next? |
|
|
May 3, 2012 |
375 |
| Anti-HIV drug use during pregnancy does not affect infant size, birth weight. |
|
|
May 1, 2012 |
124 |
| Immunel supports immune modulation. |
|
Clinical report |
May 1, 2012 |
161 |
| Antiretrovirals may help prevent HIV. |
Currie, Donya |
|
May 1, 2012 |
208 |
| Research and Markets: Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market. |
|
|
Apr 30, 2012 |
400 |
| MicroDose Therapeutx Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV). |
|
|
Apr 24, 2012 |
606 |
| All-Oral Hepatitis C Virus Treatment with Bristol-Myers Squibb's Investigational Compounds Daclatasvir and Asunaprevir Achieved Sustained Virologic Response in 77% of Difficult-to-Treat Patients. |
|
|
Apr 19, 2012 |
1329 |
| Gilead Sciences to Present New Hepatitis B and C Data at European Conference on Liver Disease This Week. |
|
Conference news |
Apr 18, 2012 |
1735 |
| Vertex Advances INCIVEK[TM] (telaprevir) and Broad Portfolio of Medicines in Development With Goal of Further Expanding and Improving Treatment for People With Hepatitis C. |
|
|
Apr 18, 2012 |
3267 |
| Antiretroviral switch linked to drop in BMD. |
London, Susan |
|
Apr 15, 2012 |
528 |
| San Francisco sees favorable trend in early ART initiation. |
London, Susan |
|
Apr 15, 2012 |
566 |
| Neuropsychological impairment detected early in HIV. |
London, Susan |
Clinical report |
Apr 15, 2012 |
673 |
| AHF: AIDS Patients Protest, Testify Against Ohio Plan to Ration AIDS Drugs. |
|
|
Apr 5, 2012 |
1112 |
| Tuberculosis screening before anti-hepatitis C virus therapy in prisons. |
Babudieri, Sergio; Soddu, Andrea; Murino, Monica; Molicotti, Paola; Muredda, Alberto A.; Madeddu, Gi |
Case study |
Apr 1, 2012 |
1366 |
| Acceptability, feasibility and impact of routine screening to detect undiagnosed HIV infection in 17-24-month-old children in the western sub-district of Cape Town. |
Levin, Michael; Mathema, Hlengani; Stinson, Kathryn; Jennings, Karen |
Report |
Apr 1, 2012 |
3440 |
| Effect of Moringa oleifera Lam. leaves powder on the evolution of hemogram profile in togolese undernourished children: evaluation on HIV-positive patients/ Effet de la poudre de feuilles de Moringa oleifera Lam. sur l'evolution du profil de l'hemogramme des enfants malnutris au togo: evaluation chez les sujets HIV positifs. |
Tete-Benissan, A.; Lawson-Evi, K.A.; Kokou, K.; Gbeassor, M. |
Report |
Apr 1, 2012 |
7730 |
| Some prescription drugs inhibit 17P metabolism. |
Worcester, Sharon |
|
Apr 1, 2012 |
772 |
| Cancer cells send out alarm to warn against tumour-killing virus. |
|
|
Mar 16, 2012 |
457 |
| Getting HIV-positive set into care challenging. |
London, Susan |
Survey |
Mar 15, 2012 |
801 |
| Data Show Gilead's Quad Regimen for HIV Non-Inferior to Protease-Based Regimen at 48 Weeks in Second Pivotal Phase 3 Study. |
|
Clinical report |
Mar 9, 2012 |
1674 |
| Gilead's Quad Single Tablet Regimen for HIV Non-Inferior to Atripla[R] in Pivotal Phase 3 Study. |
|
|
Mar 7, 2012 |
1632 |
| False-positive HIV DNA PCR testing of infants: implications in a changing epidemic. (Original Articles). |
Feucht, Ute; Forsyth, Brian; Kruger, Mariana |
Report |
Mar 1, 2012 |
4002 |
| Why it's time to say goodbye to stavudine ... everywhere. |
Andrieux-Meyer, Isabelle; Clayden, Polly; Collins, Simon; Geffen, Nathan; Goemaere, Eric; Harrington |
Report |
Mar 1, 2012 |
2876 |
| Low-dose stavudine trials: a public health priority for developing countries. |
Venter, W.D. Francois; Innes, Steve; Cotton, Mark |
Report |
Mar 1, 2012 |
2153 |
| Safety, strength and simplicity of efavirenz in pregnancy. |
Pillay, Prinitha; Black, Vivian |
Report |
Mar 1, 2012 |
6047 |
| Access to antiretroviral treatment in South Africa, 2004-2011. |
Johnson, Leigh F. |
Report |
Mar 1, 2012 |
15233 |
| Maternal and infant health is protected by antiretroviral drug strategies that preserve breastfeeding by HIV-positive women. |
Kuhn, Louise |
Report |
Mar 1, 2012 |
4676 |
| Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children. |
Markum, Eric; Baillie, John |
Report |
Mar 1, 2012 |
4165 |
| Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study. |
Lee, Eric S.; Heller, Misha M.; Kamangar, Faranak; Park, Kelly K.; Koo, John Y.M. |
Clinical report |
Mar 1, 2012 |
1594 |
| Drug resistance during follow up of a case with HIV infection/HIV enfeksiyonu nedeniyle izlenen bir olguda gelisen ilac direnci. |
Yildiz, Basak; Gokengin, Deniz; Ciftdogan, Dilek Yilmaz; Vardar, Fadil |
Letter to the editor |
Mar 1, 2012 |
852 |
| In vitro anti-viral effect of [beta]-santalol against influenza viral replication. |
Paulpandi, Manickam; Kannan, Soundarapandian; Thangam, Ramar; Kaveri, Krishnasamy; Gunasekaran, Pala |
Report |
Mar 1, 2012 |
3120 |
| AHF Challenges FDA Move to Fast Track Gilead's 'HIV Prevention' Drug Linked to Kidney Disease. |
|
|
Feb 16, 2012 |
680 |
| In vitro anti-influenza virus activity of a cardiotonic glycoside from Adenium obesum (Forssk.). |
Kiyohara, Hiroaki; Ichino, Chikara; Kawamura, Yuka; Nagai, Takayuki; Sato, Noriko; Yamada, Haruki; S |
Report |
Feb 15, 2012 |
3258 |
| U.S. FDA Grants Priority Review for Truvada[R] for Reducing the Risk of Acquiring HIV Infection. |
|
|
Feb 14, 2012 |
597 |
| Research and Markets: Global HIV Drugs Market 2010-2014 Report - The Global HIV Drugs Market to Reach US$15.5 Billion By 2014. |
|
|
Feb 14, 2012 |
404 |
| NanoViricides to Present at the 14th Annual BIO-CEO Conference in NYC today. |
|
Conference news |
Feb 13, 2012 |
1293 |
| Nevirapine and co-trimoxazole prophylaxis safe in HIV-exposed, uninfected infants. |
|
|
Feb 1, 2012 |
1017 |
| A facial marker in facial wasting rehabilitation. |
Rauso, Raffaele; Tartaro, Gianpaolo; Freda, Nicola; Rusciani, Antonio; Curinga, Giuseppe |
Report |
Feb 1, 2012 |
4100 |
| Efficacy and tolerability assessment of a topical formulation containing copper sulfate and Hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial. |
Clewell, Amy; Barnes, Matt; Endres, John R.; Ahmed, Mansoor; Ghambeer, Daljit K.S. |
Report |
Feb 1, 2012 |
4947 |
| Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. |
Storms, Aaron D.; Gubareva, Larisa V.; Su, Su; Wheeling, John T.; Okomo-Adhiambo, Margaret; Pan, Cha |
|
Feb 1, 2012 |
2612 |
| How times have changed--HIV and AIDS in South Africa in 2011. |
Pillay, Y.; White, C.; McCormick, N. |
Editorial |
Feb 1, 2012 |
1317 |
| Nurse initiation and maintenance of patients on antiretroviral therapy: are nurses in primary care clinics initiating ART after attending NIMART training? |
Cameron, David; Gerber, Amor; Mbatha, Melusi; Mutyabule, Judith; Swart, Helga |
Report |
Feb 1, 2012 |
1901 |
| Entry point of hepatitis C virus identified. |
|
|
Jan 25, 2012 |
390 |
| THE effects of anti-viral drug [...]. |
|
|
Jan 23, 2012 |
235 |
| First Hepatitis C Treatment Data Demonstrating Proof of Principle with Direct-Acting Antiviral-only Therapy Published. |
|
|
Jan 18, 2012 |
1582 |
| Prophylactic use of antiretroviral medications may prevent HIV spread. |
|
|
Jan 17, 2012 |
157 |
| Vitamin D may improve bone health in those taking anti-HIV drug. |
|
Brief article |
Jan 10, 2012 |
104 |
| Research and Markets: Global HIV Drug Pipeline Capsule 2012: highlighting key research and development activities across the globe. |
|
|
Jan 10, 2012 |
390 |
| Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs. |
|
|
Jan 9, 2012 |
875 |
| Roche's Novel Tests for the Management of Hepatitis C Virus Infection Receive CE Mark. |
|
|
Jan 5, 2012 |
611 |
| Hepatitis C virus hijacks liver microRNAs to survive. |
|
|
Jan 3, 2012 |
386 |
| SQU team to study genetic factors in AIDS treatment. |
|
|
Jan 2, 2012 |
873 |
| Keep a Child Alive: an African mother's desperate plea for help prompted an international outpouring of support. |
Mayfield, James |
|
Jan 1, 2012 |
1229 |
| Guideline on invasive obstetric procedures in the HIV-infected pregnant woman. |
Mnyani, C.N.; Nicolaou, E.; Bera, E.; Black, V.; Hull, J.C.; McIntyre, J.A. |
Report |
Jan 1, 2012 |
2106 |
| Raltegravir-based HIV therapy bests efavirenz. |
Mahoney, Diana |
|
Jan 1, 2012 |
599 |
| U.S. FDA Accepts New Drug Application for Gilead's Once-Daily, Single-Tablet Quad HIV Regimen. |
|
|
Dec 23, 2011 |
634 |
| Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV. |
|
|
Dec 21, 2011 |
2131 |
| FDA Expands Use of HIV Drug Isentress to Children and Adolescents. |
|
|
Dec 21, 2011 |
717 |
| AHF Salutes Merck for AIDS Drug Price Cuts for Hard-Hit Programs. |
|
|
Dec 21, 2011 |
983 |
| Delaware Chancery Court Denies SIGA Technologies' Motion for Reargument. |
|
|
Dec 19, 2011 |
1475 |
| New Roche Screening Test for Abacavir Hypersensitivity Available in Europe. |
|
|
Dec 16, 2011 |
899 |
| AHF Slams Gilead "HIV Prevention Pill" FDA Application. |
|
|
Dec 16, 2011 |
1097 |
| Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret[R] against viruses causing respiratory infections. |
Glatthaar-Saalmuller, B.; Rauchhaus, U.; Rode, S.; Haunschild, J.; Saalmuller, A. |
Report |
Dec 15, 2011 |
5523 |
| How to combat cold sores; THINK PHARMACY FIRST. |
|
|
Dec 12, 2011 |
377 |
| Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIV. |
|
|
Dec 9, 2011 |
1111 |
| AHF Targets Merck Over AIDS Drug Pricing. |
|
|
Dec 8, 2011 |
670 |
| AHF Praises J&J for AIDS Drug Price Cut, Asks Merck to Follow Suit. |
|
|
Dec 8, 2011 |
672 |
| AHF Salutes Gilead on Price Cuts for US AIDS Drug Program. |
|
|
Dec 5, 2011 |
1077 |
| Green tea flavonoid helps prevent hepatitis C virus from entering liver. |
|
|
Dec 2, 2011 |
382 |
| Does HIV services decentralization protect against the risk of catastrophic health expenditures? Some lessons from Cameroon. |
Boyer, Sylvie; Abu-Zaineh, Mohammad; Blanche, Jerome; Loubiere, Sandrine; Bonono, Renee-Cecile; Moat |
Survey |
Dec 1, 2011 |
11083 |
| Feeding HIV-exposed infants. |
Myer, Landon |
Editorial |
Dec 1, 2011 |
716 |
| How should we care for patients who are not yet eligible for art? |
Boyles, Tom H.; Wilkinson, Lynne S. |
Viewpoint essay |
Dec 1, 2011 |
2582 |
| Why should we still care about the stavudine dose? |
Innes, Steve; Cotton, Mark; Venter, Francois |
Viewpoint essay |
Dec 1, 2011 |
1519 |
| Identifying missed opportunities for early intervention among HIV-infected paediatric admissions at Chris Hani Baragwanath Hospital, Soweto, South Africa. |
Dramowski, Angela; Coovadia, Ashraf; Meyers, Tammy; Goga, Ameena |
Report |
Dec 1, 2011 |
5325 |
| Successful treatment of bilateral visual loss caused by idiopathic optic neuritis in an HIV-infected patient. |
Cullen, Claire; Matlala, Baile; Laher, Fatima; Pienaar, Ane |
Case study |
Dec 1, 2011 |
2397 |
| Khayelitsha 2001-2011: 10 years of primary care HIV and TB programmes. |
Garone, Daniela Belen; Hilderbrand, Katherine; Boulle, Andrew M.; Coetzee, David; Goemaere, Eric; Va |
|
Dec 1, 2011 |
4535 |
| AHF to Stage "Occupy Gilead" Protest Over Gilead's AIDS Drug Prices. |
|
|
Nov 30, 2011 |
1286 |
| Inhibitex Reports Recent Clinical and Corporate Developments. |
|
|
Nov 29, 2011 |
1372 |
| Gilead Receives European Marketing Authorization for Eviplera[R], a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naove Adults. |
|
|
Nov 28, 2011 |
1666 |
| NIH Discontinues Tenofovir Vaginal Gel in 'VOICE' HIV Prevention Study. |
|
Brief article |
Nov 25, 2011 |
107 |
| Vioxx: Merck Continues Bad Behavior With AIDS Drug Pricing, Says AHF. |
|
|
Nov 23, 2011 |
546 |
| Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion. |
|
|
Nov 21, 2011 |
2137 |
| Research and Markets: The HIV Drugs Market in India to Reach US$54 Million by 2014 According To Recent Report. |
|
|
Nov 21, 2011 |
385 |
| UN Reports Death and Infections Down Due to AIDS Drugs - Funding Must Go Up, Says AHF. |
|
|
Nov 21, 2011 |
595 |
| Gilead Sciences Finalizes Agreement with Tibotec Pharmaceuticals to Develop and Commercialize a Single-Tablet Regimen of Prezista[R] with Emtriva[R], GS 7340 and Cobicistat. |
|
|
Nov 15, 2011 |
855 |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz[R] (atazanavir sulfate) in Brazil. |
|
|
Nov 11, 2011 |
379 |
| Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting. |
|
|
Nov 11, 2011 |
782 |
| Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences. |
|
Conference news |
Nov 9, 2011 |
644 |
| ShangPharma Announces Milestone in Drug Candidate Program for Biotica. |
|
|
Nov 8, 2011 |
817 |
| Why Did Healthy Children Fall Critically Ill in the 2009 H1N1 Flu Pandemic? |
|
|
Nov 7, 2011 |
1373 |
| Gilead Announces Positive Five-Year Data Showing Effect of Viread[R] on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B. |
|
|
Nov 5, 2011 |
2079 |
| Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668. |
|
|
Nov 4, 2011 |
987 |
| AHF to Stage "Day of the Dead" Funeral Procession to Protest Gilead's AIDS Drug Prices. |
|
|
Nov 2, 2011 |
1544 |
| Baseline chest radiographic features of HIV-infected children eligible for antiretroviral therapy. |
du Plessis, Vicci; Andronikou, Savvas; Struck, Gabriel; McKerrow, Neil; Stoker, Aisne |
Clinical report |
Nov 1, 2011 |
4449 |
| Deaths associated with pandemic (H1N1) 2009 among children, Japan, 2009-2010. |
Okumura, Akihisa; Nakagawa, Satoshi; Kawashima, Hisashi; Muguruma, Takashi; Saito, Osamu; Fujimoto, |
Clinical report |
Nov 1, 2011 |
6405 |
| Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11. |
Sleeman, Katrina; Sheu, Tiffany G.; Moore, Zack; Kilpatrick, Susan; Garg, Shikha; Fry, Alicia M.; Gu |
Clinical report |
Nov 1, 2011 |
3422 |
| Erosive and desquamative syphilis associated with mucositis in the setting of acquired immune deficiency Syndrome. |
Ouertermous, James; Bernardi, Michael; Malone, Janine; Callen, Jeffrey P. |
Case study |
Nov 1, 2011 |
912 |
| HIV testing update. |
Cohen, Jenny K.; Klausner, Jeffrey D. |
Report |
Nov 1, 2011 |
5418 |
| HIV treatment and reproductive health in the health system in Burkina Faso: resource allocation and the need for integration. |
Windisch, Ricarda; de Savigny, Don; Onadja, Genevieve; Somda, Antoine; Wyss, Kaspar; Sie, Ali; Kouya |
|
Nov 1, 2011 |
7707 |
| Extended use of infant prophylaxis during breastfeeding reduces risk of HIV infection by over 70%. |
|
Brief article |
Nov 1, 2011 |
231 |
| Viroblock Closes Series C Financing Round. |
|
|
Oct 28, 2011 |
339 |
| Over the Next Decade, the Dominance of Bristol-Myers Squibb/Gilead's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Gilead/Janssen's Complera. |
|
|
Oct 27, 2011 |
629 |
| NanoViricides' Anti-Virus Technology Published in Bionanotechnology II: Global Prospects. |
|
|
Oct 24, 2011 |
759 |
| Cats engineered to resist disease: genetic tweak may foster immunity to HIV- like virus. |
Saey, Tina Hesman |
|
Oct 22, 2011 |
483 |
| NIH researchers show how anti-HIV drug acts to block herpes virus. |
|
Brief article |
Oct 20, 2011 |
105 |
| Early HIV Treatment Dramatically Increases Survival in Patients Co-Infected With Tuberculosis. |
|
|
Oct 19, 2011 |
1182 |
| HIV/AIDS Organizations Tell FDA and Gilead Sciences: Don't Delay HIV Prevention for Gay and Bisexual Men and Transgender Women. |
|
|
Oct 18, 2011 |
1834 |
| Merck's ISENTRESS[R] (raltegravir) in Combination Therapy Demonstrated Virological and Immunological Efficacy Versus the Efavirenz Regimen at 192 Weeks of Treatment in Previously Untreated Adults with HIV-1. |
|
|
Oct 13, 2011 |
5798 |
| AHF: Global Fund Rejects Request To End U.S. AIDS Drug Crisis. |
|
|
Oct 13, 2011 |
509 |
| Research and Markets: Antiviral Drug Development. |
|
|
Oct 11, 2011 |
353 |
| United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program. |
|
|
Oct 10, 2011 |
770 |
| Hepatitis C Landscape is Changing as the New Protease Inhibitors are Adopted into Clinical Practice. |
|
|
Oct 6, 2011 |
736 |
| Gilead and Boehringer Ingelheim Sign License Agreement for Novel HIV Non-Catalytic Integrase Inhibitors. |
|
|
Oct 5, 2011 |
808 |
| Over 380,000 Malawians on free HIV drugs: officials. |
|
|
Oct 5, 2011 |
183 |
| Research and Markets: Antiviral Drugs: From Basic Discovery Through Clinical Trials. |
|
|
Oct 4, 2011 |
342 |
| Santaris Pharma A/S to Report New Clinical Data From Miravirsen Phase 2a Study to Treat Hepatitis C in Late-Breaking Oral Presentation at the AASLD 2011 Annual Meeting. |
|
Clinical report |
Oct 3, 2011 |
1354 |
| Research and Markets: New Research Looks at Antiviral Markets with Projections to 2020. |
|
|
Oct 3, 2011 |
473 |
| Kineta Scientists to Present Novel Antiviral Research Findings at International Conference. |
|
Conference news |
Oct 3, 2011 |
581 |
| HIV prevention and treatment for South African men who have sex with men. |
Rebe, Kevin B.; Struthers, Helen; de Swardt, Glenn; McIntyre, James A. |
Report |
Oct 1, 2011 |
2028 |
| Antiviral activity of dehydroascorbic acid. |
Kitt, Douglas |
Report |
Oct 1, 2011 |
529 |
| Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010. |
Calatayud, Laurence; Lackenby, Angie; Reynolds, Arlene; McMenamin, Jim; Phin, Nick F.; Zambon, Maria |
|
Oct 1, 2011 |
6629 |
| Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean Immigrant. |
Bansal, Vineeta; Metzner, Karin J.; Niederost, Barbara; Leemann, Christine; Boni, Jurg; Gunthard, Hu |
Letter to the editor |
Oct 1, 2011 |
1216 |
| A practical approach to the diagnosis and management of paradoxical tuberculosis immune reconstitution inflammatory syndrome: TB-associated immune reconstitution inflammatory syndrome is seen after the initiation of antiretroviral therapy. |
Meintjes, Graeme; Sonderup Mark W. |
Disease/Disorder overview |
Oct 1, 2011 |
3707 |
| TB and HIV co-infection: when to start antiretroviral therapy: guidelines on when to start therapy in TB and HIV co-infection. |
Bekker, Linda-Gail |
|
Oct 1, 2011 |
4317 |
| Tb epidemiology in HIV-prevalent settings. |
Middelkoop, Keren |
|
Oct 1, 2011 |
895 |
| AHF Hosts NJ Protest & 'Die-In' over J&J's AIDS Drug Prices--September 30th. |
|
|
Sep 30, 2011 |
1242 |
| Booze hits body's ability to ward off viral infections. |
|
|
Sep 30, 2011 |
299 |
| Common painkillers could be used to treat fatal cancers. |
|
|
Sep 29, 2011 |
217 |
| NIH modifies VOICE HIV prevention study in women. |
|
Brief article |
Sep 28, 2011 |
118 |
| New compound kills several viruses, including deadly Spanish flu. |
|
|
Sep 27, 2011 |
234 |
| MicroDose Therapeutx Begins Phase 1 Trial of MDT-637 for Treatment of Respiratory Syncytial Virus. |
|
|
Sep 27, 2011 |
492 |
| Enanta's Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of Windhover's Top 10 Infectious Disease Projects to Watch. |
|
|
Sep 26, 2011 |
645 |
| New compound kills several viruses, including deadly Spanish flu. |
|
|
Sep 26, 2011 |
234 |
| European CHMP Adopts Positive Opinion for Eviplera[R], a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection. |
|
|
Sep 23, 2011 |
792 |
| AHF Sues FDA over Information on Gilead's HIV Prevention Pill. |
|
|
Sep 23, 2011 |
972 |
| PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court. |
|
|
Sep 22, 2011 |
986 |
| Rethinking health promotion and disease prevention in Africa: the quest for an integrated model. |
Kidanemariam, Adnemariam |
Report |
Sep 22, 2011 |
7099 |
| New Treatment for Hepatitis C Helps Boost Cure Rate. |
|
|
Sep 21, 2011 |
382 |
| SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus. |
|
|
Sep 20, 2011 |
639 |
| Sharks 'to protect us from dengue, yellow fever, and hepatitis'. |
|
|
Sep 20, 2011 |
237 |
| Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients. |
|
|
Sep 19, 2011 |
987 |
| BioCryst To Present New Peramivir Data at the 51st Annual ICAAC Meeting. |
|
Conference news |
Sep 17, 2011 |
1151 |
| Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting. |
|
Conference news |
Sep 16, 2011 |
848 |
| Teva Announces Drug Development Investment in Cocrystal Discovery Inc. for Novel Antiviral Therapeutics. |
|
|
Sep 15, 2011 |
1164 |
| AHF Requests $50M Help from Global Fund, Warren Buffett to End AIDS Drug Crisis in US. |
|
|
Sep 15, 2011 |
1682 |
| OPKO Announces Investment by Teva in Cocrystal Discovery Inc. |
|
|
Sep 15, 2011 |
599 |
| Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP). |
|
|
Sep 15, 2011 |
948 |
| AHF Hosts Third "Die-in" Protest Over Gilead's AIDS Drug Prices. |
|
|
Sep 13, 2011 |
1457 |
| AIDS Advocates to J & J: 'AIDS Drug Prices to Die For!'; Sept. 9th Protest, New Brunswick, NJ--12:30pm. |
|
|
Sep 9, 2011 |
1163 |
| Protein signals that help our body remember viral infections identified. |
|
|
Sep 3, 2011 |
267 |
| Recent studies raise hope for all-virus protection. |
Schlaberg, Robert |
Brief article |
Sep 1, 2011 |
274 |
| HIV and antiretroviral therapy. |
|
Brief article |
Sep 1, 2011 |
400 |
| Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. |
Hurley, E.; Coutsoudis, A.; Giddy, J.; Knight, S.E.; Loots, E.; Esterhuizen, T.M. |
Clinical report |
Sep 1, 2011 |
5537 |
| Dual and triple therapy to prevent mother-to-child transmission of HIV in a resource-limited setting--lessons from a South African programme. |
Geddes, Rosemary; Giddy, Janet; Butler, Lisa M.; van Wyk, Erika; Crankshaw, Tamaryn; Esterhuizen, To |
Report |
Sep 1, 2011 |
3243 |
| Antiretroviral medications can reduce risk for HIV infections. |
Currie, Donya |
|
Sep 1, 2011 |
149 |
| Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. |
Atkins, Charisma Y.; Patel, Anita; Taylor, Thomas H., Jr.; Biggerstaff, Matthew; Merlin, Toby L.; Du |
|
Sep 1, 2011 |
6178 |
| Intrahousehold transmission of pandemic (H1N1) 2009 virus, Victoria, Australia. |
van Gemert, Caroline; Hellard, Margaret; McBryde, Emma S.; Fielding, James; Spelman, Tim; Higgins, N |
|
Sep 1, 2011 |
6016 |
| Seroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, England. |
Johnson, Sandra; Ihekweazu, Chikwe; Hardelid, Pia; Raphaely, Nika; Hoschler, Katja; Bermingham, Alis |
|
Sep 1, 2011 |
5933 |
| When to start antiretroviral therapy in adults: the results of HPTN 052 move us closer to a 'test-and-treat policy. |
Geffen, Nathan |
Report |
Sep 1, 2011 |
2345 |
| Antimicrobial resistance and health care-associated infections: combating this global threat, part 1. |
DePaola, Louis G.; Fried, Jacquelyn L. |
|
Sep 1, 2011 |
2177 |
| AHF Spearheads 'Pill Bottle Protest' Over Gilead's AIDS Drug Prices. |
|
|
Aug 31, 2011 |
1040 |
| LabCorp Introduces HCV Resistance Testing through Monogram Biosciences with the Launch of HCV GenoSure[R] NS3/4A. |
|
|
Aug 25, 2011 |
785 |
| HIV Experts Create the Roadmap for Providing PrEP to Uninfected Individuals to Reduce the Risk of HIV Infection. |
|
|
Aug 24, 2011 |
1978 |
| Gilead PrEP Campaign Leads to Truvada Black Market in Florida, AHF Says. |
|
|
Aug 19, 2011 |
935 |
| AHF Stages Second "Die-in" & Protest Over Gilead's AIDS Drug Prices. |
|
|
Aug 18, 2011 |
818 |
| Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients. |
|
|
Aug 16, 2011 |
868 |
| AHF Hosts NJ Protest & 'Die-In' Over J&J's AIDS Drug Prices--August 17th Noon. |
|
|
Aug 16, 2011 |
1328 |
| SOUTH AFRICA : South Africa to offer better provision of anti-AIDS drugs. |
|
|
Aug 16, 2011 |
230 |
| NanoViricides Reports HIVCide Exhibited Long Term Sustained Anti-HIV Effects Even After Drug Discontinuation. |
|
|
Aug 15, 2011 |
1308 |
| Why some HIV cocktails pack a bigger punch: steep dose-response curves explain drugs' characteristics. |
Ehrenberg, Rachel |
|
Aug 13, 2011 |
765 |
| AHF: Gilead's Pricing of Complera May Break Hard-Hit AIDS Drug Programs. |
|
|
Aug 11, 2011 |
860 |
| AHF: Sen. Rubio (R, FL) Offers Obama Administration Proposal to End Growing AIDS Drug Crisis. |
|
|
Aug 8, 2011 |
858 |
| Research and Markets: Atazanavir - Industry Benchmark Comprehensive Patent Search. |
|
|
Aug 5, 2011 |
405 |
| AHF Hosts Protest & "Die-in" Over Gilead's AIDS Drug Prices. |
|
|
Aug 3, 2011 |
1523 |
| AHF: Victory! Boehringer Ingelheim to Increase AIDS Drug Program Rebates. |
|
|
Aug 3, 2011 |
670 |
| Antiretroviral drugs. |
|
|
Aug 1, 2011 |
105 |
| Overdose with HAART--are we managing these patients adequately? |
Gabler, Tarryn; Yudelowitz, Bradley; Mahomed, Adam |
Letter to the editor |
Aug 1, 2011 |
1487 |
| High prevalence of comorbidity and need for up-referral among inpatients at a district-level hospital with specialist tuberculosis services in South Africa--the need for specialist support. |
van der Plas, Helen; Mendelson, Marc |
Report |
Aug 1, 2011 |
2754 |
| Encapsulation of hydrophobic drugs in a copolymer: glass transition behavior and miscibility evaluation. |
Babu, R.Jayachandra; Brostow, Witold; Fasina, Oladiran; Kalogeras, Loannis M.; Sathigari, Sateeshkum |
Report |
Aug 1, 2011 |
6740 |
| Ecotoxicologic risks during an influenza pandemic. |
|
Brief article |
Aug 1, 2011 |
203 |
| Assessing the ecotoxicologic hazards of a pandemic influenza medical response. |
Singer, Andrew C.; Colizza, Vittoria; Schmitt, Heike; Andrews, Johanna; Balcan, Duygu; Huang, Wei E. |
Report |
Aug 1, 2011 |
6692 |
| Antiretroviral use by uninfected cut HIV. |
Wendling, Patrice |
|
Aug 1, 2011 |
814 |
| Prophylactic ART use raises questions for practice. |
Smith, Jennie |
|
Aug 1, 2011 |
450 |
| HIV prophylaxis will rely on primary care physicians. |
Sweet, Donna E. |
|
Aug 1, 2011 |
561 |
| Hormonal contraception, BV may up HIV risk: HIV risk was nearly 3-fold higher in men whose infected female partner had bacterial vaginosis. |
Smith, Jennie |
|
Aug 1, 2011 |
757 |
| Fracture rate does not appear to rise with HIV regimens. |
|
|
Aug 1, 2011 |
484 |
| Articular syndromes in association with HIV infection: although articular manifestations as a result of HIV infection, apart from arthralgia, are uncommon, they may result in considerable morbidity. |
Mody, Girish M.; Patel, Neeta |
Report |
Aug 1, 2011 |
2839 |
| Control and prevention of viral gastroenteritis. |
Monroe, Stephan S. |
|
Aug 1, 2011 |
1088 |
| Cost-effectiveness of sick leave policies for health care workers with influenza-like illness, Brazil, 2009. |
Mota, Nancy Val y Val P.; Lobo, Renata D.; Toscano, Cristiana M.; de Lima, Antonio C. Pedroso; Dias, |
|
Aug 1, 2011 |
5930 |
| Use of medical care during pandemic (H1N1) 2009, Navarre, Spain. |
Burgui, Rosana; Martinez-Baz, Ivan; Guevara, Marcela; Carlos, Silvia; Castilla, Jesus |
Disease/Disorder overview |
Aug 1, 2011 |
2267 |
| Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child. |
Eshaghi, AliReza; Patel, Samir N.; Sarabia, Alicia; Higgins, Rachel R.; Savchenko, Alexei; Stojios, |
|
Aug 1, 2011 |
2388 |
| Sexual dissatisfaction and associated factors in a sample of patients on antiretroviral treatment in KwaZulu-Natal, South Africa. |
Peltzer, Karl |
Report |
Aug 1, 2011 |
4235 |
| SOUTH AFRICA : Western Cape celebrates milestone of 100,000 patients on Anti-Retroviral Treatment(ART). |
|
|
Jul 27, 2011 |
489 |
| AHF: AIDS Protesters to Merck: 'Do the Right Thing!' on Drug Prices -- NJ Protest, July 28th. |
|
|
Jul 27, 2011 |
1763 |
| Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK[TM] Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks. |
|
|
Jul 26, 2011 |
3161 |
| Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate. |
|
|
Jul 26, 2011 |
745 |
| AHF: AIDS Protesters to J & J: 'No More Tears!' on AIDS Drug Pricing--July 27th NJ Protest. |
|
|
Jul 26, 2011 |
1564 |
| NanoViricides Reports Anti-HIV Efficacy Equivalent to HAART Drug Cocktail Treatment in Animal Study, Successfully Advancing its HIVCide Lead Optimization Program. |
|
Report |
Jul 25, 2011 |
1477 |
| Obama Administration Decision May Force Florida to Pull AIDS Medications from Existing Patients. |
|
|
Jul 25, 2011 |
536 |
| INCIVO(R) Receives Positive Opinion From the Committee for Medicinal Products for Human use (CHMP) for the Treatment of Genotype-1 Hepatitis C Virus (HCV). |
|
|
Jul 22, 2011 |
1415 |
| In the Real Life Setting, Boosted REYATAZ (atazanavir/ritonavir) Proves as Effective in Women Living with HIV as Men. |
|
Clinical report |
Jul 20, 2011 |
1172 |
| EDURANT(TM) 96-Week Phase 3 Safety and Efficacy Data Presented at International AIDS Society Conference. |
|
Conference news |
Jul 19, 2011 |
1857 |
| VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C. |
|
|
Jul 18, 2011 |
2148 |
| Merck's ISENTRESS[R] (raltegravir) in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1. |
|
Clinical report |
Jul 18, 2011 |
2942 |
| Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development of New Formulations. |
|
|
Jul 15, 2011 |
2883 |
| Silymarin efficacy against influenza A virus replication. |
Song, J.H.; Choib, H J. |
Report |
Jul 15, 2011 |
2123 |
| Ranbaxy,Gilead Sciences to manufacture and market three anti-HIV drugs in India, developing nations. |
|
|
Jul 14, 2011 |
339 |
| New means of overcoming antiviral resistance in influenza found. |
|
|
Jul 14, 2011 |
247 |
| Antiretroviral drugs reduce risk of HIV infection. |
|
|
Jul 14, 2011 |
304 |
| HIV Drugs Reduce Transmission Risk for Heterosexual Couples. |
|
|
Jul 13, 2011 |
520 |
| Anti-HIV Drugs Prevent Infection in Healthy Heterosexuals, An End to the HIV Epidemic? |
|
|
Jul 13, 2011 |
317 |
| AHF to Protest Bay Area's Gilead Sciences over AIDS Drug Pricing at SF's Fed Building. |
|
|
Jul 13, 2011 |
1363 |
| Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients. |
|
|
Jul 13, 2011 |
1279 |
| Mylan Receives Voluntary License Rights to Gilead's HIV/AIDS Pipeline Products in Developing World. |
|
|
Jul 12, 2011 |
549 |
| AHF Lauds Gilead as First to Share AIDS Drug Patents with New Global Patent Pool. |
|
|
Jul 12, 2011 |
507 |
| The prevalence of hepatitis B infection in a rural South African HIV clinic. |
Boyles, Tom H.; Cohen, Karen |
Report |
Jul 1, 2011 |
1664 |
| New ARV info 'a cause of anxiety in patients'. |
Bateman, Chris |
|
Jul 1, 2011 |
189 |
| Doctors to FDA: "HIV Prevention Pill" Not Ready for Approval. |
|
|
Jun 29, 2011 |
1155 |
| AHF Challenges Gilead over AIDS Drug Pricing During Protest at Foster City HQ. |
|
|
Jun 29, 2011 |
880 |
| Filligent's BioFriend[TM] BioMask[TM] Wins FDA Clearance For First Ever Anti-Viral Face Mask. |
|
|
Jun 28, 2011 |
1150 |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz[R] (atazanavir sulfate) in sub-Saharan Africa and India. |
|
|
Jun 28, 2011 |
425 |
| Atlanta TONIGHT: Rep. John Lewis to Appear at AIDS Drug Crisis Town Hall. |
|
|
Jun 28, 2011 |
1130 |
| Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract. |
|
|
Jun 27, 2011 |
1048 |
| HIV drugs linked to premature aging. |
|
|
Jun 27, 2011 |
118 |
| Tobira Therapeutics Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection. |
|
|
Jun 22, 2011 |
636 |
| NanoViricides, Inc. to Present at OneMedForum NY 2011 Trans-Atlantic Conference for Emerging Healthcare and Life Science Companies. |
|
Conference news |
Jun 22, 2011 |
785 |
| Complex care in the community. |
Thompson, Alison |
Report |
Jun 22, 2011 |
2854 |
| Country file: HIV community care for those who live outside cities. |
Broughton, Charlotte |
Viewpoint essay |
Jun 22, 2011 |
2305 |
| Artemis Resources Limited (ASX:ARV) Assembles World-Class Technical Team For Gold Projects. |
|
|
Jun 16, 2011 |
562 |
| Characterization, molecular cloning, and in silico analysis of a novel mannose-binding lectin from Polygonatum odoratum (Mill.) with anti-HSV-II and apoptosis-inducing activities. |
Yang, Yun; Xu, Huai-long; Zhang, Zi-ting; Liu, Jun-jie; Li, Wen-wen; Ming, Hua; Bao, Jin-ku |
Report |
Jun 15, 2011 |
6648 |
| Bacterial infection often follows on heels of viral infection. |
London, Susan |
|
Jun 15, 2011 |
458 |
| AIDS Advocates to Rally at Ohio Statehouse Over AIDS Drug Crisis. |
|
|
Jun 13, 2011 |
869 |
| Massive Opportunity Exists in Hepatitis C Market for Recently Approved Protease Inhibitors Victrelis and Incivek According to a New Report by BioTrends Research Group. |
|
|
Jun 13, 2011 |
555 |
| AHF Slams Feds for Pressing Florida to Cut Eligibility for Lifesaving AIDS Drug Program. |
|
|
Jun 10, 2011 |
986 |
| HIV-infected people 'prone to developing life-threatening cancers'. |
|
|
Jun 7, 2011 |
291 |
| Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. |
Pebody, Richard G.; Harris, Ross; Kafatos, George; Chamberland, Mary; Campbell, Colin; Nguyen-Van-Ta |
Clinical report |
Jun 1, 2011 |
6696 |
| Research and Markets: HIV - Better Differential Pricing Strategies are Needed to Ensure Access to HIV Drugs. |
|
|
Jun 1, 2011 |
376 |
| Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598). |
|
|
Jun 1, 2011 |
1096 |
| Underutilization of the AIDS drug assistance program: associated factors and policy implications. |
Godwin, Noah C.; Willig, James H.; Nevin, Christa R.; Lin, Hui-Yi; Allison, Jeroan; Gaddis, Kathy; P |
Clinical report |
Jun 1, 2011 |
4867 |
| Immediate HIV treatment saves costs. |
van Niekerk, J.P. de V. |
Brief article |
Jun 1, 2011 |
260 |
| How different are the costs and consequences of delayed versus immediate HIV treatment? |
Welte, Alex; Hargrove, John; Delva, Wim; Williams, Brian; Stander, Tienie |
Report |
Jun 1, 2011 |
1419 |
| Rehabilitation: a crucial component in the future of HIV care and support. |
Nixon, Stephanie; Forman, Lisa; Hanass-Hancock, Jill; Mac-Seing, Muriel; Munyanukato, Norbert; Myezw |
Report |
Jun 1, 2011 |
2866 |
| INH preventive therapy (IPT) in HIV-infected South African children. |
Cotton, Mark F. |
Report |
Jun 1, 2011 |
2715 |
| Guideline on safer conception in fertile HIV-infected individuals and couples. |
Bekker, L.-G.; Black, V.; Myer, L.; Rees, H.; Cooper, D.; Mall, S.; Mnyami, C.; Conradie, F.; Mahabe |
Report |
Jun 1, 2011 |
11063 |
| Trans-hiatal oesophagectomy in an aids patient. |
de Zoysa, M.I.M.; Sivaganesh, S.; Abayadeera, A.U.; Buddhakorale, K. |
Case study |
Jun 1, 2011 |
975 |
| Longer anti-HIV therapy is worth the cost. |
Rosenberg, Jared |
|
Jun 1, 2011 |
408 |
| South African women's childbearing plans are unrelated to ART use. |
Rosenberg, J. |
Report |
Jun 1, 2011 |
706 |
| Study on Cammomile (Matricaria chamomilla L.) usage and farming. |
Mohammad, Sharrif moghaddasi |
Report |
Jun 1, 2011 |
5062 |
| Antiretroviral adverse drug reactions and their management: how to recognise, manage and avoid adverse effects of antiretrovirals. |
Orrell, Catherine |
|
Jun 1, 2011 |
3250 |
| Treatment as prevention. |
Alcorn, Keith |
|
Jun 1, 2011 |
841 |
| Research and Markets: Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment. |
|
|
May 31, 2011 |
328 |
| DIA Announces Recipients of the Inaugural President's Award for Outstanding Achievement in World Health. |
|
Awards list |
May 31, 2011 |
715 |
| Artemis Resources Limited (ASX:ARV) Exercise Of Listed Options And News Update. |
|
|
May 30, 2011 |
434 |
| Artemis Resources Limited (ASX:ARV) Shareholders Newsletter. |
|
|
May 30, 2011 |
187 |
| Artemis Resources Limited (ASX:ARV) Encountered High Grade Silver And Copper Grades At Bali Hi Project. |
|
|
May 25, 2011 |
581 |
| Study shows promise for preventive vaccine against HIV/AIDS. |
|
|
May 24, 2011 |
251 |
| New drug that can kill cervical cancer virus on the anvil. |
|
|
May 23, 2011 |
157 |
| FDA Approves New HIV Treatment. |
|
|
May 20, 2011 |
727 |
| Abbott Receives FDA Approval for Molecular Test for Hepatitis C. |
|
|
May 18, 2011 |
1019 |
| VIDEO from Abbott and Synaptic Digital: Abbott Receives FDA Approval for Molecular Test for Hepatitis C. |
|
|
May 18, 2011 |
441 |
| Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. |
Agyare, Christian; Lechtenberg, Matthias; Deters, Alexandra; Petereit, Frank; Hensel, Andreas |
|
May 15, 2011 |
6713 |
| Protease inhibitors poised to improve HCV outcomes. |
Mechcatie, Elizabeth |
|
May 15, 2011 |
554 |
| FDA Approves Merck's VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. |
|
|
May 14, 2011 |
4124 |
| Scientists create new anti-flu virus proteins using computer design. |
|
|
May 14, 2011 |
244 |
| Early HIV therapy 'can dramatically cut virus spread to partners'. |
|
|
May 13, 2011 |
478 |
| FDA Approves Merck's VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. |
|
|
May 13, 2011 |
4039 |
| Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052). |
|
Clinical report |
May 12, 2011 |
1327 |
| Traces of Fungicide Found in HIV Drug. |
|
|
May 12, 2011 |
365 |
| Artemis Resources Limited (ASX:ARV) Announce Yandal Gold Results Intersects Up To 28g/t. |
|
Financial report |
May 4, 2011 |
856 |
| Widely used HIV drug could help prevent cervical cancer. |
|
|
May 4, 2011 |
310 |
| CYPRUS : Contract for supplies of antivirals for systemic use awarded by Farmakeytikes Ypiresies. |
|
|
May 4, 2011 |
124 |
| HIV drugs can also kill malaria parasites: Study. |
|
|
May 3, 2011 |
166 |
| AHF's Board Opposes FDA-approval of Gilead's AIDS Drug Truvada as HIV Prevention. |
|
|
May 3, 2011 |
855 |
| Antiretroviral prescriptions with potential drug-drug interactions from general practitioners and specialists. |
Katende-Kyenda, Norah L.; Lubbe, M.S.; Serfontein, J.H.P.; Truter, I.; Bodenstein, J. |
Letter to the editor |
May 1, 2011 |
1995 |
| Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. |
Nwobegahay, Julius; Bessong, Pascal; Masebe, Tracy; Mavhandu, Lufuno; Manhaeve, Cecile; Ndjeka, Norb |
Report |
May 1, 2011 |
2070 |
| Increasing access to antiretroviral therapy for HIV-infected adults and children. |
|
|
May 1, 2011 |
771 |
| Use of minocycline in viral infections. |
Dutta, Kallol; Basu, Anirban |
Report |
May 1, 2011 |
2512 |
| Sexual relations and childbearing decisions of HIV-discordant couples" an exploratory study in South Africa and Tanzania. |
Rispel, Laetitia C.; Metcalf, Carol A.; Moody, Kevin; Cloete, Allanise; Caswell, Georgina |
Report |
May 1, 2011 |
6137 |
| Post-natal ARV prophylaxis for infants: efficacy of extended nevirapine. |
|
Brief article |
May 1, 2011 |
272 |
| Inequalities in determinants of health among Aboriginal and Caucasian persons living with HIV/AIDS in Ontario: results from the positive spaces, healthy places study. |
Monette, Laverne E.; Rourke, Sean B.; Gibson, Katherine; Bekele, Tsegaye M.; Tucker, Ruthann; Greene |
Report |
May 1, 2011 |
4415 |
| HIV management in practice: South Africa has the largest HIV epidemic in the world and it is therefore imperative that all health care workers are knowledgeable about the management of HIV/AIDS. |
Rossouw, Theresa M. |
|
May 1, 2011 |
2742 |
| Counselling, not alarm device, had best effect on antiretroviral adherence. |
Leach-Lemens, Carole |
|
May 1, 2011 |
839 |
| AHF to Question Abbott on AIDS Drug Pricing During April 29 AGM in Abbott Park. |
|
|
Apr 29, 2011 |
787 |
| Trading of Vertex Common Stock Halted Today. |
|
|
Apr 28, 2011 |
1366 |
| FDA Advisory Committee Unanimously Recommends Approval of Telaprevir for People with Hepatitis C. |
|
|
Apr 28, 2011 |
1876 |
| Hepatitis B Virus Reemerges with Long-term Nucleoside Analog Treatment. |
|
|
Apr 27, 2011 |
837 |
| Potentially most effective anti-shingles drug announced. |
|
Brief article |
Apr 22, 2011 |
233 |
| Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637 for Treatment of Respiratory Syncytial Virus. |
|
|
Apr 20, 2011 |
900 |
| AHF: Gilead Must Halt FDA Approval of Truvada as HIV Prevention After PrEP Study in Women Fails. |
|
|
Apr 18, 2011 |
875 |
|
